Literature DB >> 31216425

Mitochondrial dynamics and transport in Alzheimer's disease.

Padraig J Flannery1, Eugenia Trushina2.   

Abstract

Mitochondrial dysfunction is now recognized as a contributing factor to the early pathology of multiple human conditions including neurodegenerative diseases. Mitochondria are signaling organelles with a multitude of functions ranging from energy production to a regulation of cellular metabolism, energy homeostasis, stress response, and cell fate. The success of these complex processes critically depends on the fidelity of mitochondrial dynamics that include the ability of mitochondria to change shape and location in the cell, which is essential for the maintenance of proper function and quality control, particularly in polarized cells such as neurons. This review highlights several aspects of alterations in mitochondrial dynamics in Alzheimer's disease, which may contribute to the etiology of this debilitating condition. We also discuss therapeutic strategies to improve mitochondrial dynamics and function that may provide an alternative approach to failed amyloid-directed interventions.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Axonal trafficking; Fission; Fusion; Mitochondria; Mitochondria-targeted therapeutics; Mitophagy

Mesh:

Year:  2019        PMID: 31216425      PMCID: PMC6614006          DOI: 10.1016/j.mcn.2019.06.009

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  168 in total

1.  The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.

Authors:  Aurélien Olichon; Laurent J Emorine; Eric Descoins; Laetitia Pelloquin; Laetitia Brichese; Nicole Gas; Emmanuelle Guillou; Cécile Delettre; Annie Valette; Christian P Hamel; Bernard Ducommun; Guy Lenaers; Pascale Belenguer
Journal:  FEBS Lett       Date:  2002-07-17       Impact factor: 4.124

2.  Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Nairita Roy; Lewis Hutfles; Jeffrey M Burns; Elias K Michaelis; ShiDu Yan; Sandra M Cardoso; Russell H Swerdlow
Journal:  Hum Mol Genet       Date:  2013-06-04       Impact factor: 6.150

3.  Effects of resveratrol on the rat brain respiratory chain.

Authors:  R Zini; C Morin; A Bertelli; A A Bertelli; J P Tillement
Journal:  Drugs Exp Clin Res       Date:  1999

4.  Tau reduction prevents Abeta-induced defects in axonal transport.

Authors:  Keith A Vossel; Kai Zhang; Jens Brodbeck; Aaron C Daub; Punita Sharma; Steven Finkbeiner; Bianxiao Cui; Lennart Mucke
Journal:  Science       Date:  2010-09-09       Impact factor: 47.728

5.  Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.

Authors:  P Hemachandra Reddy; Maria Manczak; Ramesh Kandimalla
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

6.  Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

Authors:  Maria Manczak; Ramesh Kandimalla; David Fry; Hiromi Sesaki; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

7.  KIF5B motor adaptor syntabulin maintains synaptic transmission in sympathetic neurons.

Authors:  Huan Ma; Qian Cai; Wenbo Lu; Zu-Hang Sheng; Sumiko Mochida
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

8.  OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.

Authors:  Christian Frezza; Sara Cipolat; Olga Martins de Brito; Massimo Micaroni; Galina V Beznoussenko; Tomasz Rudka; Davide Bartoli; Roman S Polishuck; Nika N Danial; Bart De Strooper; Luca Scorrano
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

Review 9.  Disturbed mitochondrial dynamics and neurodegenerative disorders.

Authors:  Florence Burté; Valerio Carelli; Patrick F Chinnery; Patrick Yu-Wai-Man
Journal:  Nat Rev Neurol       Date:  2014-12-09       Impact factor: 42.937

10.  Sigma-1 Receptor Activation Induces Autophagy and Increases Proteostasis Capacity In Vitro and In Vivo.

Authors:  Maximilian G Christ; Heike Huesmann; Heike Nagel; Andreas Kern; Christian Behl
Journal:  Cells       Date:  2019-03-02       Impact factor: 6.600

View more
  39 in total

Review 1.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 2.  Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage.

Authors:  Yu-Hang Jiang; Jia-Kai He; Ran Li; Ze-Hao Chen; Bao-Hui Jia
Journal:  Chin J Integr Med       Date:  2022-03-01       Impact factor: 1.978

3.  Stress and Psychiatric Disorders: The Role of Mitochondria.

Authors:  Teresa E Daniels; Elizabeth M Olsen; Audrey R Tyrka
Journal:  Annu Rev Clin Psychol       Date:  2020-02-24       Impact factor: 18.561

Review 4.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 5.  The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.

Authors:  Sanjib Guha; Gail V W Johnson; Keith Nehrke
Journal:  Mol Neurobiol       Date:  2020-08-26       Impact factor: 5.590

6.  The role of mitophagy in the regulation of mitochondrial energetic status in neurons.

Authors:  Sinsuk Han; Mingyang Zhang; Yu Young Jeong; David J Margolis; Qian Cai
Journal:  Autophagy       Date:  2021-04-05       Impact factor: 16.016

Review 7.  Blood-Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration.

Authors:  Alla B Salmina; Ekaterina V Kharitonova; Yana V Gorina; Elena A Teplyashina; Natalia A Malinovskaya; Elena D Khilazheva; Angelina I Mosyagina; Andrey V Morgun; Anton N Shuvaev; Vladimir V Salmin; Olga L Lopatina; Yulia K Komleva
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 8.  Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer's disease.

Authors:  Lakshmi Jaya Madhuri Bandaru; Neelima Ayyalasomayajula; Lokesh Murumulla; Suresh Challa
Journal:  Biometals       Date:  2022-01-20       Impact factor: 2.949

9.  A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor.

Authors:  Huanyao Gao; Utkarsh Tripathi; Sergey Trushin; Lela Okromelidze; Nicholas P Pichurin; Lixuan Wei; Yongxian Zhuang; Liewei Wang; Eugenia Trushina
Journal:  Mitochondrion       Date:  2021-02-19       Impact factor: 4.160

10.  Neuroprotective Effects of VEGF-A Nanofiber Membrane and FAAH Inhibitor URB597 Against Oxygen-Glucose Deprivation-Induced Ischemic Neuronal Injury.

Authors:  Da-Peng Wang; Kai-Yan Jin; Peng Zhao; Qi Lin; Kai Kang; Jian Hai
Journal:  Int J Nanomedicine       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.